Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
John S. Patton
AddedMar 31, 2024
UpdatedMay 31, 2026
John S. Patton

John S. Patton

Co-Founder, Halozyme Therapeutics

CrunchbaseLinkedIn

John S. Patton's Career

Halozyme Therapeutics
Halozyme Therapeutics

San Diego, CA, US

Co-Founder
Nektar Therapeutics
Nektar Therapeutics

San Francisco, CA, US

Founder
InCarda Therapeutics
InCarda Therapeutics

Newark, CA, US

Co-Founder
Aerami Therapeutics
Aerami Therapeutics

Durham, NC, US

Founder

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

John S. Patton's Career

Halozyme Therapeutics
Halozyme Therapeutics
Public$745M3931998San Diego, CA, US
Co-Founder

Leadership at Halozyme Therapeutics

Matt PosardMatt PosardBoard Member
Kate FalbergKate FalbergBoard Member
Helen TorleyHelen TorleyBoard Member
Gregory FrostGregory FrostCo-Founder
Barbara DuncanBarbara DuncanBoard Member
KarwishKarwishBoard Member

Similar to Halozyme Therapeutics

Heron TherapeuticsHeron TherapeuticsSan Diego, CA, USPharmaceuticalsest. 1983Heron TherapeuticsSan Diego, CA, US · est. 1983

Heron Therapeutics: A US-based biotech firm enhancing injectable pharmaceuticals via proprietary drug delivery tech.

Public · $974M203
Denali TherapeuticsDenali TherapeuticsSan Francisco, CA, USBiotechest. 2015Denali TherapeuticsSan Francisco, CA, US · est. 2015

Denali Therapeutics, a US-based biotech firm, develops medicines for neurodegenerative diseases.

Public · $622M427
Gyre TherapeuticsGyre TherapeuticsSan Diego, CA, USBiopharmaceuticalsest. 1997Gyre TherapeuticsSan Diego, CA, US · est. 1997

San Diego-based Gyre Therapeutics develops and commercializes Hydronidone, a leading biopharmaceutical.

Public75
Nektar Therapeutics
Nektar Therapeutics
Public$1.2B2161990San Francisco, CA, US
Founder

Leadership at Nektar Therapeutics

Rob ChessRob ChessBoard Member
R. Scott GreerR. Scott GreerBoard Member
Howard RobinHoward RobinBoard Member
Roy WhitfieldRoy WhitfieldBoard Member

Similar to Nektar Therapeutics

NKT TherapeuticsNKT TherapeuticsWaltham, MA, USTherapeuticsest. 2008NKT TherapeuticsWaltham, MA, US · est. 2008

NKT Therapeutics: A US-based biotech firm dedicated to developing treatments for cancer and serious diseases.

Series A · $12M8
NeuroTherapeutics PharmaNeuroTherapeutics PharmaChicago, IL, USPharmaceuticals, Therapeuticsest. 2006NeuroTherapeutics PharmaChicago, IL, US · est. 2006

NeuroTherapeutics Pharma: A US-based biopharmaceutical firm specializing in neuropathic and acute pain treatments.

Public · $60.7M30
Neurona TherapeuticsNeurona TherapeuticsSouth San Francisco, CA, USCell Therapiesest. 2008Neurona TherapeuticsSouth San Francisco, CA, US · est. 2008

Neurona Therapeutics: Leading provider of cell-based medicines for neurological disorders.

Series A · $200.3M58
Nerx BiosciencesNerx BiosciencesIndianapolis, IN, USCancer Therapeuticsest. 2009Nerx BiosciencesIndianapolis, IN, US · est. 2009

US-based NĒRx BioSciences Inc, founded in 2009, specializes in discovering and developing targeted cancer therapeutics.

Seed · $500k11
InCarda Therapeutics
InCarda Therapeutics
Series A$86.4M102009Newark, CA, US
Co-Founder

Leadership at InCarda Therapeutics

George BickerstaffGeorge BickerstaffBoard Member
Gregory M. MarcusGregory M. MarcusCo-Founder
Adam FreundAdam FreundCo-Founder
Narsi RangachariNarsi RangachariCo-Founder
Robert LisickiRobert LisickiCEO
Carlos SchulerCarlos SchulerCo-Founder

Similar to InCarda Therapeutics

Cardeas PharmaCardeas PharmaSeattle, WA, USAntibiotics, Pharmaceuticalsest. 2010Cardeas PharmaSeattle, WA, US · est. 2010

Cardeas Pharma: Specializing in developing inhaled antibiotics for respiratory infections.

Series B · $80M30
BioCardiaBioCardiaSan Carlos, CA, USMedical Devices, Therapeuticsest. 1999BioCardiaSan Carlos, CA, US · est. 1999

BioCardia, a San Carlos-based medical firm, develops innovative regenerative therapies for critical cardiovascular diseases.

Public · $41.3M28
Respira TherapeuticsRespira TherapeuticsAlbuquerque, NM, USDrug Delivery, Inhalationest. 2010Respira TherapeuticsAlbuquerque, NM, US · est. 2010

Respira: A drug delivery tech company specializing in efficient dry powder inhaler technologies.

Series B · $5.1M9
Cardurion PharmaceuticalsCardurion PharmaceuticalsBurlington, MA, USTherapeuticsest. 2017Cardurion PharmaceuticalsBurlington, MA, US · est. 2017

Boston-based biotech firm specializing in next-gen therapeutics for heart diseases.

Series B · $343.1M42
Aerami Therapeutics
Aerami Therapeutics
Series B$133.5M182010Durham, NC, US
Founder

Leadership at Aerami Therapeutics

Anne WhitakerAnne WhitakerBoard Member
Don HuffmanDon HuffmanBoard Member
Darlene Deptula-HicksDarlene Deptula-HicksBoard Member
Joshua ZielJoshua ZielCEO

Similar to Aerami Therapeutics

Aer TherapeuticsAer TherapeuticsRaleigh, NC, USBiopharmaceuticalsest. 2014Aer TherapeuticsRaleigh, NC, US · est. 2014

Aer Therapeutics: Clinical-stage biopharma developing treatments for severe respiratory diseases.

Series A · $36M12
Respira TherapeuticsRespira TherapeuticsAlbuquerque, NM, USDrug Delivery, Inhalationest. 2010Respira TherapeuticsAlbuquerque, NM, US · est. 2010

Respira: A drug delivery tech company specializing in efficient dry powder inhaler technologies.

Series B · $5.1M9
Aero TherapeuticsAero TherapeuticsSan Diego, CA, USMedical Devicesest. 2019Aero TherapeuticsSan Diego, CA, US · est. 2019

Aero Therapeutics: Developing respiratory aid devices for low-resource settings.

Seed · $180k6
Aerwave MedicalAerwave MedicalNaples, FL, USMedical Devicesest. 2020Aerwave MedicalNaples, FL, US · est. 2020

Aerwave Medical: Pioneering non-drug COPD and asthma treatments since 2020, based in New York.

Seed · $8M7

John S. Patton's Similar Executives & Operators

Achmad ZakyAchmad ZakyCo-Founder · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakBo ZhangBo ZhangCo-Founder · DiDiWILL WEI CHENGWILL WEI CHENGCo-Founder · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniFounder · Reliance RetailKim Beom-sooKim Beom-sooCo-Founder · KakaoBrian KimBrian KimCo-Founder · KakaoJB LEEJB LEECo-Founder · Kakao

People Similar to John S. Patton

James C. KatzaroffJames C. KatzaroffBoard Member · GlobeStar TherapeuticsDavid EvansDavid EvansBoard Member · TruistDan PiacquadioDan PiacquadioFounder · TherapeuticsJohn LiJohn LiFounder · Shenzhen Salubris Pharmaceuticals Co.Michael DetmerMichael DetmerCo-Founder · Innovative TherapeutixDon DavidsonDon DavidsonCo-Founder · Creative BioTherapeutics